Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
285
datasets available to search
ShareScore release 0.9.0
Dataset results
285 results for “regorafenib”
Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT05425940. IPD Sharing: NO. Countries: 16. Publications: 2.
Phase II Study of Regorafenib Continuous Dosing of Regorafenib in Patients With GISTs
ClinicalTrials.gov study NCT02889328. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
PAnitumumab REchallenge Followed by REgorafenib Versus the Reverse Sequence
ClinicalTrials.gov study NCT04787341. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors
ClinicalTrials.gov study NCT03475953. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma
ClinicalTrials.gov study NCT02406170. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cadonilimab Combined With Regorafenib as A Third-line Treatment in Patients With MSS CRLM
ClinicalTrials.gov study NCT06455254. IPD Sharing: YES. Countries: 1. Publications: 10.
Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated in Patients With Previously Treated Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT03880877. IPD Sharing: NO. Countries: 1. Publications: 2.
Regorafenib in Subjects With Metastatic Colorectal Cancer (mCRC) Who Have Progressed After Standard Therapy
ClinicalTrials.gov study NCT01853319. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Analysis of cfDNA in Patients With Hepatocarcinoma and Treated by Sorafenib or Regorafenib
ClinicalTrials.gov study NCT03956940. IPD Sharing: NO. Countries: 1. Publications: 15.
Open Label Regorafenib Study to Evaluate Cardiovascular Safety Parameters, Tolerability, and Anti-tumor Activity
ClinicalTrials.gov study NCT01339104. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Regorafenib Assessment in Refractory Advanced Colorectal Cancer(RegARd-C)
ClinicalTrials.gov study NCT01929616. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Regorafenib Combined With PD-1 Inhibitor Therapy for Second-line Treatment of Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05048017. IPD Sharing: Not stated. Countries: 1. Publications: 18.
Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST
ClinicalTrials.gov study NCT02638766. IPD Sharing: NO. Countries: 3. Publications: 1.
JS001 Combined With Regorafenib in Patients With Advanced Colorectal Cancer
ClinicalTrials.gov study NCT03946917. IPD Sharing: NO. Countries: 1. Publications: 5.
A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer
ClinicalTrials.gov study NCT02773524. IPD Sharing: Not stated. Countries: 7. Publications: 3.
A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas
ClinicalTrials.gov study NCT02389244. IPD Sharing: NO. Countries: 1. Publications: 3.
HAIC Combined With Cadonilimab and Regorafenib as 2nd-line Treatment for ICC
ClinicalTrials.gov study NCT06335927. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib for Recurrent Grade 2 and 3 Meningioma (MIRAGE Trial)
ClinicalTrials.gov study NCT06275919. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
The Aim of This Study is to Assess the Efficacy and Safety of Chidamide, Regorafenib in Combination With Iparomlimab and Tuvonralimab for the Treatment of Advanced Colorectal Cancer in Third-line Ther
ClinicalTrials.gov study NCT06930118. IPD Sharing: UNDECIDED. Countries: 1. Publications: 35.
Determination of Safety, Efficacy, and Pharmacokinetics of "Regorafenib" Combined With Pemetrexed and Cisplatin in Patients With Nonsquamous Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01187615. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.